- Home
- CARE vs PRTA Comparison
CARE vs PRTA Comparison
Compare CARE & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARE
- PRTA
- Stock Information
- Founded
- CARE 1974
- PRTA 2012
- Country
- CARE United States
- PRTA Ireland
- Employees
- CARE N/A
- PRTA N/A
- Industry
- CARE Major Banks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- CARE Finance
- PRTA Health Care
- Exchange
- CARE Nasdaq
- PRTA Nasdaq
- Market Cap
- CARE 396.9M
- PRTA 472.1M
- IPO Year
- CARE N/A
- PRTA N/A
- Fundamental
- Price
- CARE $19.46
- PRTA $8.20
- Analyst Decision
- CARE Buy
- PRTA Buy
- Analyst Count
- CARE 2
- PRTA 10
- Target Price
- CARE $21.50
- PRTA $14.86
- AVG Volume (30 Days)
- CARE 71.3K
- PRTA 1.2M
- Earning Date
- CARE 10-23-2025
- PRTA 08-04-2025
- Dividend Yield
- CARE N/A
- PRTA N/A
- EPS Growth
- CARE 154.06
- PRTA N/A
- EPS
- CARE 1.36
- PRTA N/A
- Revenue
- CARE $153,120,000.00
- PRTA $10,341,000.00
- Revenue This Year
- CARE $10.85
- PRTA N/A
- Revenue Next Year
- CARE $14.12
- PRTA $389.77
- P/E Ratio
- CARE $14.31
- PRTA N/A
- Revenue Growth
- CARE 21.78
- PRTA N/A
- 52 Week Low
- CARE $13.61
- PRTA $4.32
- 52 Week High
- CARE $20.40
- PRTA $22.83
- Technical
- Relative Strength Index (RSI)
- CARE 70.53
- PRTA 58.73
- Support Level
- CARE $18.42
- PRTA $8.05
- Resistance Level
- CARE $19.80
- PRTA $8.73
- Average True Range (ATR)
- CARE 0.43
- PRTA 0.38
- MACD
- CARE 0.11
- PRTA -0.05
- Stochastic Oscillator
- CARE 84.04
- PRTA 47.62
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.